PolyPid (PYPD) Earnings Analysis
PolyPid (PYPD) next reports earnings on 2026-08-12, consensus EPS -0.365 USD. Last quarter (2026-02-11) it missed with EPS -0.41 USD vs -0.34 USD est (-20.6%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E -2.09.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PYPD next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.365 USD |
| Revenue estimate | 0.00B |
PYPD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-11 | -0.41 USD | -0.34 USD | -20.6% | Miss |
| 2025-08-13 | -0.78 USD | -0.53 USD | -47.2% | Miss |
| 2025-05-14 | -0.7 USD | -0.8 USD | +12.5% | Beat |
| 2025-02-12 | -1.13 USD | -0.9 USD | -25.6% | Miss |
| 2024-11-13 | -1.22 USD | -1.07 USD | -14% | Miss |
| 2024-08-14 | -1.25 USD | -1.51 USD | +17.2% | Beat |
Beat rate: 2/6 (33%) over reported quarters with consensus data.
PYPD valuation and analyst view
| Trailing P/E | -2.09 |
|---|---|
| Trailing EPS | -1.53388 USD |
| Price / book | 9.99 |
| Dividend yield | 0.00% |
| Market cap | 0.04B |
| Analyst consensus | Buy (8 buy / 1 hold / 0 sell) |
| Avg price target | 12.5 USD |
Related research pages
Frequently asked questions
When is PolyPid (PYPD)'s next earnings date?
PolyPid is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.365 USD and revenue estimate of 0.00B.
Did PYPD beat earnings last quarter?
In its 2026-02-11 report, PYPD posted EPS of -0.41 USD versus a -0.34 USD estimate — a miss of 20.6%.
What is PYPD's earnings track record?
Over the last 6 reported quarters with consensus data, PYPD beat estimates 2 times (33%).
What is PYPD's current P/E ratio and EPS?
PYPD trades at a trailing P/E of -2.09 on trailing EPS of -1.5338762982062784 USD.
What do analysts rate PYPD?
Analyst consensus is "Buy" across 9 ratings (0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 12.5 USD.